Notice ID: 8bb1dbfd54404efa956a3490205a834bJustificationAwarded
Award to Immport Therapeutics, Inc.
Awarded on September 1, 2020. Full description on SAM.gov.
Overview
- Posted
- September 1, 2020
- Notice type
- Justification
- Agency
- Department of Health and Human ServicesCENTERS FOR DISEASE CONTROL AND PREVENTION
Notice details
- Office
- CDC NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES
- Place of performance
- Irvine, CA, 92618
- Last updated
- Apr 29, 2026
- Award date
- Sep 1, 2020
- Award amount (SAM.gov award notice)
- Not specified
Identifiers
- Solicitation number
- 75D301-20-Q-72561
- Notice ID
- 8bb1dbfd54404efa956a3490205a834b
Description
The Centers for Disease Control and Prevention (CDC), Office of Acquisition Services (OAS) on behalf of the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Deputy Director for Public Health Service and Implementation Science (DDPHSIS), Center for Preparedness and Response (CPR) has awarded a purchase order to Immport Therapeutics, Inc dba Antigen Discovery Inc for the procurement of encoded recombinant proteins by in vitro transcription/translation (IVTT) reactions of SARS-CoV2, SARS-CoV, MERS, and HCoVs ~350 clones and the printing of the proteins including controls onto custom nitrocellulose-coated microarray slides. This award was made in accordance with FAR Part 18.
Award Overview
Award Number
75D30120P09676
Award Amount (SAM.gov award notice)
Not specified
Award Date
Sep 1, 2020
Awardee
Not specified
Original Solicitation
Notice ID: 8bb1dbfd54404efa956a3490205a834b
Posted Date: Sep 1, 2020
Original Response Deadline: Not specified
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75D301-20-Q-72561- Awarded
This opportunity has been awarded.
- Sole Source / J&ACurrentSep 1, 2020
Award to Immport Therapeutics, Inc.
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75D301-20-Q-72561
Archive Date
Sep 15, 2020
Office Address
Atlanta, GA, 30333